As of close of business last night, Ngm Biopharmaceuticals Inc’s stock clocked out at $1.53, down -6.13% from its previous closing price of $1.63. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 1569631 shares were traded. NGM stock price reached its highest trading level at $1.6100 during the session, while it also had its lowest trading level at $1.5200.
Ratios:
To gain a deeper understanding of NGM’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.92 and its Current Ratio is at 7.92. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On May 03, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $6.Citigroup initiated its Buy rating on May 03, 2023, with a $6 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 16 when COLUMN GROUP L P bought 5,840 shares for $0.62 per share. The transaction valued at 3,627 led to the insider holds 949,862 shares of the business.
COLUMN GROUP L P bought 5,840 shares of NGM for $3,627 on Nov 16. The Director now owns 949,862 shares after completing the transaction at $0.62 per share. On Nov 16, another insider, COLUMN GROUP L P, who serves as the Director of the company, bought 5,840 shares for $0.62 each. As a result, the insider paid 3,627 and bolstered with 949,862 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NGM now has a Market Capitalization of 127.70M and an Enterprise Value of -36.97M. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.64 while its Price-to-Book (P/B) ratio in mrq is 0.75. Its current Enterprise Value per Revenue stands at -1.65 whereas that against EBITDA is 0.23.
Stock Price History:
The Beta on a monthly basis for NGM is 1.28, which has changed by -62.61% over the last 52 weeks, in comparison to a change of 27.55% over the same period for the S&P500. Over the past 52 weeks, NGM has reached a high of $4.83, while it has fallen to a 52-week low of $0.60. The 50-Day Moving Average of the stock is 1.3191, while the 200-Day Moving Average is calculated to be 1.7772.
Shares Statistics:
It appears that NGM traded 1.21M shares on average per day over the past three months and 1.89M shares per day over the past ten days. A total of 81.89M shares are outstanding, with a floating share count of 45.14M. Insiders hold about 45.42% of the company’s shares, while institutions hold 25.98% stake in the company. Shares short for NGM as of Feb 15, 2024 were 1.66M with a Short Ratio of 1.38, compared to 1.54M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.00% and a Short% of Float of 7.51%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.31 and a low estimate of -$0.66, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.29 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.7 and -$2.08 for the fiscal current year, implying an average EPS of -$1.79. EPS for the following year is -$1.2, with 5 analysts recommending between -$0.55 and -$1.63.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for NGM’s current fiscal year. The highest revenue estimate was $6.25M, while the lowest revenue estimate was $4.25M, resulting in an average revenue estimate of $4.83M. In the same quarter a year ago, actual revenue was $55.33M, down -91.30% from the average estimate.
